AstraZeneca has just announced "positive results" from its SUPERNOVA Phase III trial on sipavibart (AZD3152), the updated version of Evusheld:
astrazeneca.com/media-centr...
The press release states that they are in touch with regulatory authorities on developing a pathway for approval, so perhaps it will become available some time in the next few months (perhaps sooner?).
On a related note, has anyone received Pemgarda (that was announced in late March)? My nephrologist - at a prominent major metropolitan medical center with a large transplant center - said that the treatment is currently not available there, due to lack of demand. Has the word not gotten out yet? (For those who are interested, I contacted Invivyd, and doses are indeed available to providers through approved distributors.)